Relationship Between Interoception and Postural Control in Constipation-Predominant Irritable Bowel Syndrome
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
Could this be for you?
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 45 years old?
Source: NCT07870915, who can take part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorTrial details
- Who runs it
- Saglik Bilimleri Universitesi
- Trial code
- NCT07870915
- Record updated
- 21 October 2026
- Original description
This cross-sectional, observational, controlled comparative study aims to investigate the relationship between interoception and postural control in individuals with constipation-predominant irritable bowel syndrome (IBS-C) and to compare the findings with those of healthy individuals. Interoception will be assessed using the Multidimensional Assessment of Interoceptive Awareness-2 (MAIA-2), postural characteristics will be evaluated using the Corbin Posture Analysis, and stool type in the IBS-C group will be assessed using the Bristol Stool Scale.Read full original descriptionShow less
Investigation of the Relationship Between Interoception and Postural Control in Constipation-Predominant Irritable Bowel Syndrome
This cross-sectional, observational, controlled comparative study aims to investigate the relationship between interoception and postural control in individuals with constipation-predominant irritable bowel syndrome (IBS-C) and to compare the findings with those of healthy individuals. Interoception will be assessed using the Multidimensional Assessment of Interoceptive Awareness-2 (MAIA-2), postural characteristics will be evaluated using the Corbin Posture Analysis, and stool type in the IBS-C group will be assessed using the Bristol Stool Scale.
Inclusion: Aged 18-45 years; For the IBS-C group, having a clinical diagnosis of constipation-predominant irritable bowel syndrome; For the control group, having no history of gastrointestinal disease; Voluntarily agreeing to participate in the study.
Exclusion: Having a neurological, rheumatological, or serious orthopedic disease; Having a history of surgery that may affect posture; Being unable to complete the assessments due to cognitive or communication impairment; Pregnancy.